| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1929449 | Biochemical and Biophysical Research Communications | 2012 | 6 Pages |
Insulin receptor substrates (IRSs) play central roles in insulin/insulin-like growth factor (IGF) signaling and mediate a variety of their bioactivities. IRSs are tyrosine-phosphorylated by activated insulin receptor/IGF-I receptor tyrosine kinase in response to insulin/IGF, and are recognized by signaling molecules possessing the SH2 domain such as phosphatidylinositol 3-kinase (PI3K), leading to the activation of downstream pathways. Recent studies have suggested that degradation of IRSs by the ubiquitin–proteasome pathway leads to impaired insulin/IGF signaling, but the precise mechanism underlying the process is still unclear. In this study, we identified deubiquitinating enzyme ubiquitin specific protease 7 (USP7) as an IRS-2-interacting protein and demonstrated that deubiquitinase activity of USP7 plays important roles in IRS-2 stabilization through the ubiquitin–proteasome pathway. In addition, insulin treatment dissociated USP7 from IRS-2, leading to degradation of IRS-2. This dissociation was prevented by treatment with LY294002, a PI3K inhibitor, indicating that insulin activation of the PI3K pathway leads to dissociation of IRS-2 from USP7 and IRS-2 degradation. We obtained similar results for IRS-1 in cells treated with insulin and for IRS-2 in cells treated with IGF-I. Taken together, this is the first report demonstrating that USP7 is an IRS-1/2 deubiquitinating enzyme forming a negative feedback loop in insulin/IGF signaling.
► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRSs are bound to deubiquitinating enzyme ubiquitin specific protease 7 (USP7). Deubiquitinase activity of USP7 plays important roles in IRS-2 stabilization. ► Insulin/IGF treatment dissociates USP7 from IRS-2, leading to degradation of IRS-2. ► This is the first report demonstrating that USP7 is IRSs deubiquitinating enzyme.
